AI Screening for Diabetic Retinopathy

• by Abraham Olvera-Barrios, MD, PhD, Cathy Egan, FRANZCO

• May 1, 2026

Investigational OCTA Devices Show Promise in Diabetic Disease Assessment

At Retina World Congress, Patricio G. Schlottmann, MD, discussed investigational widefield OCTA platforms made by Chinese company TowardPi Medical.

• by Patricio G. Schlottmann, MD, Patricio G. Schlottmann, MD

• May 14, 2026

• 2 min

Semaglutide Linked to NAION Risk

A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.

• by Andrea Surnit

• May 11, 2026

• 3 min

Oculomics: Beyond the Buzzword

Joseph J. Pizzimenti, OD, FAAO, FORS, discusses the capabilities of oculomics in retina and neuro-ophthalmology,

• by Sarah Fackler, managing editor, Optometric Management

• June 17, 2026

• 6 min